EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era

David I Bernstein, Asuncion Mejias iD, Barbara Rath iD, Christopher W Woods iD, Jamie Phillips Deeter

The Journal of Applied Laboratory Medicine · 2023

DOI: 10.1093/jalm/jfac058 ↗

Kurz gefasst

Scoping Review in der Zeitschrift The Journal of Applied Laboratory Medicine, 2023. Verfasst von David I Bernstein und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Nonpharmaceutical interventions to prevent the spread of coronavirus disease 2019 also decreased the spread of respiratory syncytial virus (RSV) and influenza. Viral diagnostic testing in patients with respiratory tract infections (RTI) is a necessary tool for patient management; therefore, sensitive and specific tests are required. This scoping literature review aimed to summarize the study characteristics of commercially available sample-to-answer RSV tests. Content PubMed and Embase were queried for studies reporting on the diagnostic performance of tests for RSV in patients with RTI (published January 2005–January 2021). Information on study design, patient and setting characteristics, and published diagnostic performance of RSV tests were extracted from 77 studies that met predefined inclusion criteria. A literature gap was identified for studies of RSV tests conducted in adult-only populations (5.3% of total subrecords) and in outpatient (7.5%) or household (0.8%) settings. Overall, RSV tests with analytical time >30 min had higher published sensitivity (62.5%–100%) vs RSV tests with analytical time ≤30 min (25.7%–100%); this sensitivity range could be partially attributed to the different modalities (antigen vs molecular) used. Molecular-based rapid RSV tests had higher published sensitivity (66.7%–100%) and specificity (94.3%–100%) than antigen-based RSV tests (sensitivity: 25.7%–100%; specificity:80.3%–100%). Summary This scoping review reveals a paucity of literature on studies of RSV tests in specific populations and settings, highlighting the need for further assessments. Considering the implications of these results in the current pandemic landscape, the authors preliminarily suggest adopting molecular-based RSV tests for first-line use in these settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsAdultHumansCOVID-19 TestingSensitivity and Specificity

Stichwörter der Autor:innen

clinicalinfectious diseasemolecular diagnosticsnucleic-acid-based testingpoint-of-care testing systemsviral diseases

Autor:innen und Institutionen

  • Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Department of Pediatrics, Division of Infectious Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
  • Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
  • Vienna Vaccine Safety Initiative, Berlin, Germany.
  • Université de Bourgogne Franche-Comté, Besançon, France.
  • ESCMID Study Group for Respiratory Viruses (ESGREV), Basel, Switzerland.

ORCID-Profile: Asuncion Mejias, Barbara Rath, Christopher W Woods

Zitieren

APA

Bernstein, D. I., Mejias, A., Rath, B., Woods, C. W., & Deeter, J. P. (2023). Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfac058

Vancouver

Bernstein DI, Mejias A, Rath B, Woods CW, Deeter JP. Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era. The Journal of Applied Laboratory Medicine. 2023. doi:10.1093/jalm/jfac058

BibTeX
@article{Bernstein2023,
  author = {Bernstein, David I and Mejias, Asuncion and Rath, Barbara and Woods, Christopher W and Deeter, Jamie Phillips},
  title = {Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2023},
  doi = {10.1093/jalm/jfac058}
}
Kostenlos starten →